Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

59.26
BATS BZX Real-Time Price
As of 2:50pm ET
 +0.67 / +1.14%
Today’s Change
52.00
Today|||52-Week Range
156.93
-47.54%
Year-to-Date

Today’s Trading

Previous close58.59
Today’s open58.60
Day’s range55.51 - 60.23
Volume51,708
Average volume (3 months)1,034,798
Market cap$2.7B
Dividend yield--
Data as of 2:50pm ET, 05/06/2016

Growth & Valuation

Earnings growth (last year)+32.52%
Earnings growth (this year)-1.58%
Earnings growth (next 5 years)+62.80%
Revenue growth (last year)+298.12%
P/E ratioNM
Price/Sales60.28
Price/Book50.16

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-2.76-11.56%
LGNDLigand Pharmaceutica...+0.58+0.49%
MDCOMedicines Co+0.60+1.71%
RAREUltragenyx Pharmaceu...+1.74+2.79%
Data as of 2:52pm ET, 05/06/2016

Financials

Last reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$82.4M
Annual profit (last year)-$61.2M
Net profit margin-74.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul L. Berns
Chief Financial Officer &
Executive Vice President
Graeme Bell
Corporate headquarters
Palo Alto, California

Forecasts

Partner Offers

Search for Jobs